PositiveID (PSID) Stock Price, News & Analysis

Company Overview

PositiveID Corporation is a diversified technology company that develops and commercializes products in the fields of rapid diagnostics, secure identification and contract manufacturing. Its core diagnostics division is focused on molecular and immunodiagnostic solutions for infectious diseases, biothreat agents and public safety applications. Leveraging proprietary assay platforms and portable detection systems, the company aims to deliver point-of-care testing capabilities to healthcare providers, first responders and research laboratories.

In addition to its diagnostic offerings, PositiveID’s secure identification business provides digital identity management and credentialing services designed to safeguard sensitive information and streamline verification processes. This segment addresses the growing need for secure access control in industries such as healthcare, financial services and government. The company also operates a contract manufacturing arm that produces custom biological reagents, assay kits and related components for third-party clients, supporting research and diagnostic projects worldwide.

Founded in the early 2000s and headquartered in Austin, Texas, PositiveID has expanded its reach through strategic partnerships, acquisitions and collaborations with federal agencies and academic institutions. Its products have been deployed across North America and abroad, with an emphasis on rapid response solutions for emerging infectious threats. Under the leadership of CEO Christopher de los Reyes and an experienced management team with backgrounds in biotechnology, security and manufacturing, the company continues to pursue innovation at the intersection of health diagnostics and secure technology.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0002
• Volume: 32.70 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PSID Stock Analysis - Frequently Asked Questions

How have PSID shares performed this year?

PositiveID's stock was trading at $0.0001 at the beginning of 2025. Since then, PSID stock has increased by 0.0% and is now trading at $0.0001.

How do I buy shares of PositiveID?

Shares of PSID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PositiveID own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PositiveID investors own include Vuzix (VUZI), Marijuana Company of America (MCOA), Bridgeline Digital (BLIN), InterCloud Systems (ICLD), XTI Aerospace (XTIA), DICK'S Sporting Goods (DKS) and Precipio (PRPO).

Company Calendar

• Today: 7/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:PSID
• CIK: 1347022
• Web: www.psidcorp.com
• Phone: 561-805-8000
• Fax: 561-805-8001
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A